Skip to main content

Axos ONE

Axos ONE
Your money deserves up to 4.51% APY.* Reach your financial goals faster. Axos ONE helps you get there with high-APY savings that's up to 11x the national average.

Featured

The Leading AI Tool for Advertising: A Comprehensive Overview

This document provides a comprehensive overview of the leading AI tool designed to revolutionize advertising. It details the tool's capabilities in generating high-conversion ad assets, providing actionable insights for campaign optimization, analyzing competitor performance, and scoring creatives before media spend. This all-in-one marketing powerhouse aims to empower businesses to outperform their competitors and maximize their return on investment. Core Capabilities This AI-powered platform offers a suite of features designed to streamline and enhance the advertising process: Product Videos: Generate compelling ad texts using proven copywriting frameworks, leveraging AI trained specifically on high-performing ad copy. Ad Creatives: Produce conversion-focused ad creatives in seconds, tailored for any advertising platform. Product Shoots: Transform simple product photos into professional-grade fashion and e-commerce images instantly with AI. Creative Utility Suite: A comprehen...

Exclusive DEALS

Exercise for individuals with bone metastases: A systematic review

 

Exercise for individuals with bone metastases: A systematic review

Highlights

- Exercise appears safe and feasible for individuals with bone metastases

 - This review found mixed efficacy results

 - The majority of trials included an element of supervised exercise

 Abstract

Background

Exercise has the potential to improve physical function and quality of life in individuals with bone metastases but is often avoided due to safety concerns. This systematic review summarizes the safety, feasibility and efficacy of exercise in controlled trials that include individuals with bone metastases.

 

Methods

MEDLINE, Embase, Pubmed, CINAHL, PEDro and CENTRAL databases were searched to July 16, 2020.

 

Results

A total of 17 trials were included incorporating aerobic exercise, resistance exercise or soccer interventions. Few (n = 4, 0.5%) serious adverse events were attributed to exercise participation, with none related to bone metastases. Mixed efficacy results were found, with exercise eliciting positive changes or no change. The majority of trials included an element of supervised exercise instruction (n = 16, 94%) and were delivered by qualified exercise professionals (n = 13, 76%).


Conclusions

Exercise appears safe and feasible for individuals with bone metastases when it includes an element of supervised exercise instruction.

 


Comments